Search


Novagali Pharma, accessing new eye therapies

Scientific Advisory Board

Meet our SAB

International experts in ophthalmology, drug delivery, and pharmaceutical development participate in planning the strategic direction of Novagali Pharma

Headed by Professor Simon Benita, Novagali’s Scientific Advisory Board is composed of:

(in alphabetical order)

 

 

Professor Penny Asbell

Professor of Ophthalmology at Mount Sinai School of Medicine (New York, USA)
Director of the Cornea Service and Refractive Surgery Center

 

Back to top

 

Professor Christophe Baudouin

Professor of Ophthalmology at Quinze-Vingts National Ophthalmology Hospital (Paris, France)

INSERM unit U598 (University Paris V, France)

 

Professor Francine Behar Cohen

Retinal surgeon at Hotel Dieu Hospital (Paris, France)

Head of the INSERM unit U598, "Physiopathology of ocular diseases: therapeutic innovations" (Paris, France)

 

Back to top

 

Professor Simon Benita

Chairman of the Scientific Advisory Board

Professor at the School of Pharmacy of the Hebrew University of Jerusalem
Co-founder of Novagali Pharma.

 

Professor Patrick Couvreur

Director of the CNRS unit UMR 8612 (School of Pharmacy, University Of Paris XI)
Director of the Doctoral school "Therapeutic Innovation"
Member of the "Académie des Technologies"

 

Back to top

 

Professor Michael Lemp

Clinical Professor of Ophthalmology, Georgetown and George Washington Universities in Washington
Editor-In-Chief of The Ocular Surface

 

Professor Kazuo Tsubota

Professor and Chairperson, Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan
Visiting Professor, Department of Ophthalmology, Tokyo Dental College, Chiba, Japan

 

Back to top



Choose your language